Skip to main content

Advertisement

Log in

Spontaneous remission of minimal change nephrotic syndrome in an elderly man

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Minimal change nephrotic syndrome (MCNS) cases achieving spontaneous remission without external factors are rarely reported. We report a case of MCNS that achieved spontaneous remission without external factors that triggered its onset. An 82-year-old male patient was admitted to the hospital for close examination of nephrotic syndrome. Renal biopsy was performed and MCNS was diagnosed. Owing to the patient’s age and history of foot and microvascular arteriovenous thrombosis, we did not start immunosuppressive drugs, including steroids, and opted for conservative management. After conservative treatment, proteinuria gradually decreased, and the patient achieved complete remission. Given that the patient had a history of urinary protein and thrombosis, recurrence of MCNS was considered again this time. In addition, the involvement of external factors that trigger the onset of MCNS was not found. In conclusion, in elderly-onset MCNS, clinicians generally hesitate to initiate treatment with an immunosuppressive drug, containing steroids, because of its many complications. Thus, our data provide valuable insight into MCNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yamamoto R, Imai E, Maruyama S, et al. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan nephrotic syndrome cohort study (JNSCS). Clin Exp Nephrol. 2020;24:526–40.

    Article  Google Scholar 

  2. Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12:332–45.

    Article  CAS  Google Scholar 

  3. Fujimoto S, Yamamoto Y, Hisanaga S, Morita S, Eto T, Tanaka K. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse. Am J Kidney Dis. 1991;17:687–92.

    Article  CAS  Google Scholar 

  4. Takei T, Koike M, Suzuki K, et al. The characteristics of relapse in adult-onset minimal-change nephrotic syndrome. Clin Exp Nephrol. 2007;11:214–7.

    Article  Google Scholar 

  5. Kikuchi H, Aoyagi M, Nagahama K, et al. Nephrotic-range proteinuria and interstitial nephritis associated with the use of a topical loxoprofen patch. Intern Med. 2014;53:1131–5.

    Article  Google Scholar 

  6. Yamashiro A, Uchida T, Ito S, Oshima N, Oda T, Kumagai H. Complete remission of minimal change disease following an improvement of lung mycobacterium avium infection. Intern Med. 2016;55:2669–72.

    Article  Google Scholar 

  7. Haruki A, Ishikawa E, Katayama K, et al. Spontaneous remission of adult-onset minimal change nephrotic syndrome associated with influenza B infection. BMC Nephrol. 2018;19:162.

    Article  Google Scholar 

  8. Black DA, Rose G, Brewer DB. Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J. 1970;3:421–6.

    Article  CAS  Google Scholar 

  9. McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 2008;20:131–7.

    Article  Google Scholar 

  10. Stuijver DJF, Majoor CJ, Van Zaane B, et al. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest. 2013;143:1337–42.

    Article  CAS  Google Scholar 

  11. Yokoyama H, Sugiyama H, Narita I, et al. Outcomes of primary nephrotic syndrome in elderly japanese: retrospective analysis of the Japan renal biopsy registry (J-RBR). Clin Exp Nephrol. 2015;19:496–505.

    Article  Google Scholar 

  12. Mak SK, Short CD, Mallick NP. Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Trans. 1996;11:2192–201.

    Article  CAS  Google Scholar 

  13. Sharp W, Olivero JJ. Venous thrombosis in nephrotic syndrome. Methodist Debakey Cardiovasc J. 2018;14:237–8.

    PubMed  PubMed Central  Google Scholar 

  14. Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. 2002;39:503–12.

    Article  CAS  Google Scholar 

  15. Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy-a modern view. Clin J Am Soc Nephrol. 2014;9:609–16.

    Article  Google Scholar 

  16. Moorthy AV, Zimmerman SW. Renal disease in the elderly: clinicopathologic analysis of renal disease in 115 elderly patients. Clin Nephrol. 1980;14:223–9.

    CAS  PubMed  Google Scholar 

  17. Kanahara K, Yorioka N, Kumagai J, et al. A case of nephrotic syndrome with rapid spontaneous remission in an elderly patient. Hiroshima J Med Sci. 1997;46:93–7.

    CAS  PubMed  Google Scholar 

  18. Işlek I, Gök F, Albayrak D, Küçüködük S. Nephrotic syndrome following cefixime therapy in a 10-month-old girl: spontaneous resolution without corticosteroid treatment. Nephrol Dial Transplant. 1999;14:2527.

    Article  Google Scholar 

  19. Ferrara P, Gatto A, Vitelli O, Liberatore P, Del Bufalo F, Bottaro G. Nephrotic syndrome following H1N1 influenza in a 3-year-old boy. Iran J Pediatr. 2012;22:265–8.

    PubMed  PubMed Central  Google Scholar 

  20. Lin CY, Hsu HC. Histopathological and immunological studies in spontaneous remission of nephrotic syndrome after intercurrent measles infection. Nephron. 1986;42:110–5.

    Article  CAS  Google Scholar 

  21. Kron MA, Hedger R. Hepatitis A-induced remission of minimal change nephropathy. Arch Intern Med. 1984;144:2279–80.

    Article  CAS  Google Scholar 

  22. Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet. 1974;2:556–60.

    Article  CAS  Google Scholar 

  23. Lai KW, Wei CL, Tan LK, et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol. 2007;18:1476–85.

    Article  CAS  Google Scholar 

  24. Cheung W, Wei CL, Seah CC, Jordan SC, Yap HK. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatr Nephrol. 2004;19:627–32.

    Article  Google Scholar 

  25. Garin EH, Mu W, Arthur JM, et al. Urinary CD80 Is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int. 2010;78:296–302.

    Article  CAS  Google Scholar 

  26. Ishimoto T, Shimada M, Araya CE, Huskey J, Garin EH, Johnson RJ. Minimal change disease: a CD80 podocytopathy? Semin Nephrol. 2011;31:320–5.

    Article  CAS  Google Scholar 

  27. Kim AH, Chung JJ, Akilesh S, et al. B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement. JCI Insight. 2017;2:e81836.

    Article  Google Scholar 

  28. Reiser J, von Gersdorff G, Loos M, et al. Induction of B7–1 in podocytes is associated with nephrotic syndrome. J Clin Invest. 2004;113:1390–7.

    Article  CAS  Google Scholar 

  29. Komatsuda A, Wakui H, Iwamoto K, et al. GATA-3 Is upregulated in peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome. Clin Nephrol. 2009;71:608–16.

    Article  CAS  Google Scholar 

  30. Iwabuchi Y, Takei T, Moriyama T, Itabashi M, Nitta K. Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment. Medicine (Baltimore). 2014;93:e300.

    Article  CAS  Google Scholar 

  31. Miyabe Y, Takei T, Iwabuchi Y, Moriyama T, Nitta K. Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome. Clin Exp Nephrol. 2016;20:103–10.

    Article  CAS  Google Scholar 

  32. Iwabuchi Y, Moriyama T, Itabashi M, Takei T, Nitta K. Rituximab as a therapeutic option for steroid-sensitive minimal change nephrotic syndrome in adults. Contrib Nephrol. 2018;195:12–9.

    Article  CAS  Google Scholar 

  33. Christiansen CF, Schmidt M, Lamberg AL, et al. Kidney Disease and risk of venous thromboembolism: a nationwide population-based case-control study. J Thromb Haemost. 2014;12:1449–54.

    Article  CAS  Google Scholar 

  34. Mahmoodi BK, Ten Kate MK, Waanders F, et al. High Absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2008;117:224–30.

    Article  Google Scholar 

  35. Ismail G, Mircescu G, Ditoiu AV, Tacu BD, Jurubita R, Harza M. Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters. Int Urol Nephrol. 2014;46:787–92.

    Article  CAS  Google Scholar 

  36. Lionaki S, Derebail VK, Hogan SL, et al. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012;7:43–51.

    Article  CAS  Google Scholar 

  37. Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol. 2008;19:135–40.

    Article  Google Scholar 

  38. Ribic C, Crowther M. Thrombosis and anticoagulation in the setting of renal or liver disease hematology. Am Soc Hematol Educ Program. 2016;2:188–95.

    Article  Google Scholar 

  39. Kumar S, Chapagain A, Nitsch D, Yaqoob MM. Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study. BMC Nephrol. 2012;13:107.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuki Chiba.

Ethics declarations

Conflict of interest

All authors have declared that no conflict of interest exists.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from the patient described in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chiba, Y., Nagasawa, T., Kin, S. et al. Spontaneous remission of minimal change nephrotic syndrome in an elderly man. CEN Case Rep 10, 301–307 (2021). https://doi.org/10.1007/s13730-020-00554-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-020-00554-x

Keywords

Navigation